IM Cannabis Corp. (IMCC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in CAD.

Revenue Annual

0 20M 40M 60M 2021: 34.1M 2022: 54.3M 2023: 48.8M 2024: 54M 2025: 54.7M 2021 2022 2023 2024 2025

Gross Profit Annual

0 3.5M 7M 10.5M 2021: 6.3M 2022: 9.2M 2023: 9.8M 2024: 8.5M 2025: 9.7M 2021 2022 2023 2024 2025

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M 2021: -23M 2022: -30.8M 2023: -12.8M 2024: -10.2M 2025: -11.6M 2021 2022 2023 2024 2025

Net Income Annual

-210M -140M -70M 0 70M 140M 210M 2021: -18.5M 2022: -191.3M 2023: -10.2M 2024: -11.8M 2025: -11.8M 2021 2022 2023 2024 2025

Cost of Revenue Annual

0 20M 40M 60M 2021: 25.5M 2022: 43M 2023: 38M 2024: 45.6M 2025: 45M 2021 2022 2023 2024 2025

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M 2021: -34.4M 2022: -12.6M 2023: -8.1M 2024: -1.1M 2025: 4.7M 2021 2022 2023 2024 2025

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M 2021: -39M 2022: -14.2M 2023: -8.7M 2024: -1.2M 2025: 4.7M 2021 2022 2023 2024 2025

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M 2019: 32M 2020: 38.6M 2021: 6M 2022: 7.5M 2023: 12.8M 2019 2020 2021 2022 2023

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.